TECON BIOLOGY Co.LTD (SHE:002100)
China
· Delayed Price · Currency is CNY 7.68
+0.23 (3.09%)
Mar 10, 2026, 12:54 PM CST
TECON BIOLOGY Co.LTD Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,171 | 8,942 | 11,973 | 11,255 | 11,517 | 11,386 | Upgrade
|
| Market Cap Growth | 19.39% | -25.31% | 6.39% | -2.28% | 1.15% | -16.27% | Upgrade
|
| Enterprise Value | 13,544 | 12,563 | 15,378 | 14,181 | 15,091 | 13,224 | Upgrade
|
| Last Close Price | 7.45 | 6.33 | 8.48 | 7.81 | 10.06 | 9.49 | Upgrade
|
| PE Ratio | 22.62 | 14.78 | - | 40.08 | - | 6.62 | Upgrade
|
| Forward PE | 21.09 | 10.10 | 27.14 | 9.79 | 27.03 | 4.67 | Upgrade
|
| PS Ratio | 0.57 | 0.52 | 0.63 | 0.66 | 0.73 | 0.95 | Upgrade
|
| PB Ratio | 1.16 | 1.05 | 1.51 | 1.17 | 1.49 | 1.66 | Upgrade
|
| P/TBV Ratio | 1.53 | 1.38 | 2.04 | 1.48 | 1.69 | 1.90 | Upgrade
|
| P/FCF Ratio | 9.86 | 16.70 | 15.95 | - | - | - | Upgrade
|
| P/OCF Ratio | 7.44 | 7.70 | 6.84 | 34.31 | 7.51 | - | Upgrade
|
| PEG Ratio | - | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | Upgrade
|
| EV/Sales Ratio | 0.77 | 0.73 | 0.81 | 0.84 | 0.96 | 1.10 | Upgrade
|
| EV/EBITDA Ratio | 8.25 | 8.24 | - | 13.00 | 60.16 | 5.47 | Upgrade
|
| EV/EBIT Ratio | 16.32 | 15.36 | - | 37.55 | - | 6.71 | Upgrade
|
| EV/FCF Ratio | 13.13 | 23.46 | 20.49 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.65 | 0.76 | 0.81 | 0.77 | 0.92 | 0.95 | Upgrade
|
| Debt / EBITDA Ratio | 3.46 | 3.81 | - | 6.76 | 28.44 | 2.68 | Upgrade
|
| Debt / FCF Ratio | 5.51 | 12.10 | 8.52 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.20 | 0.40 | 0.45 | 0.35 | 0.48 | 0.64 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.21 | 2.21 | -7.40 | 3.12 | 14.79 | 1.82 | Upgrade
|
| Net Debt / FCF Ratio | 1.72 | 6.30 | 4.76 | -3.09 | -16.91 | -2.88 | Upgrade
|
| Asset Turnover | 1.05 | 1.00 | 1.05 | 0.93 | 0.96 | 0.89 | Upgrade
|
| Inventory Turnover | 5.18 | 3.30 | 3.58 | 2.72 | 2.59 | 1.89 | Upgrade
|
| Quick Ratio | 0.90 | 0.62 | 0.52 | 0.78 | 0.60 | 0.35 | Upgrade
|
| Current Ratio | 1.73 | 1.52 | 1.26 | 2.00 | 1.52 | 1.45 | Upgrade
|
| Return on Equity (ROE) | 6.34% | 7.26% | -17.29% | 2.19% | -9.53% | 29.68% | Upgrade
|
| Return on Assets (ROA) | 3.07% | 2.98% | -4.45% | 1.29% | -1.73% | 9.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.66% | 6.83% | -10.49% | 2.71% | -4.00% | 20.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.30% | 7.40% | -13.30% | 2.90% | -4.50% | 23.60% | Upgrade
|
| Earnings Yield | 4.44% | 6.77% | -11.39% | 2.50% | -6.10% | 15.11% | Upgrade
|
| FCF Yield | 10.14% | 5.99% | 6.27% | -9.79% | -1.91% | -13.44% | Upgrade
|
| Dividend Yield | 3.02% | 3.48% | - | 2.82% | - | 4.85% | Upgrade
|
| Payout Ratio | 117.27% | 28.65% | - | 92.90% | - | 23.51% | Upgrade
|
| Buyback Yield / Dilution | -0.57% | -1.88% | -0.95% | -21.76% | -2.13% | -0.10% | Upgrade
|
| Total Shareholder Return | 2.46% | 1.60% | -0.95% | -18.94% | -2.13% | 4.74% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.